Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin.
作者信息
Rewald E, Jaksic J C
机构信息
Fundación Hematológica, Mardel Plata, Argentina.
出版信息
J R Soc Med. 1990 Oct;83(10):652-3. doi: 10.1177/014107689008301021.
Abstract
摘要
相似文献
1
Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin.大剂量静脉注射免疫球蛋白和小剂量阿司匹林治疗白塞病。
J R Soc Med. 1990 Oct;83(10):652-3. doi: 10.1177/014107689008301021.
2
A case of Behçet's disease with pulmonary arterial aneurysm and secondary amyloidosis.
Rheumatology (Oxford). 2002 Jul;41(7):831-2. doi: 10.1093/rheumatology/41.7.831-a.
3
A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.一名神经白塞病患者用依那西普治疗成功：肿瘤坏死因子α阻断价值的进一步证据
Clin Neurol Neurosurg. 2007 Apr;109(3):279-81. doi: 10.1016/j.clineuro.2006.11.002. Epub 2006 Dec 14.
4
Behçet's syndrome: response to infliximab after failure of etanercept.白塞氏综合征：依那西普治疗失败后对英夫利昔单抗的反应
Rheumatology (Oxford). 2002 Oct;41(10):1213-4.
5
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.一项双盲、随机研究，旨在调查达克珠单抗治疗白塞病相关眼部并发症的安全性和有效性。
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70. doi: 10.1080/09273940701299370.
6
[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].[白塞病与现代肿瘤坏死因子抑制药物的应用可能性]
Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9.
7
A case of mucocutaneous Behçet's disease responding to etanercept.1例对依那西普有反应的黏膜皮肤型白塞病。
J Am Acad Dermatol. 2005 Apr;52(4):717-9. doi: 10.1016/j.jaad.2004.11.031.
8
Successful treatment of resistant Behçet's disease with etanercept.用依那西普成功治疗难治性白塞病。
Clin Exp Rheumatol. 2005 Sep-Oct;23(5):729.
9
10
Biologics and Behcet's: disease diversity and trial design.生物制剂与白塞病：疾病多样性与试验设计
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):61-2. doi: 10.1080/09273940701357756.
引用本文的文献
1
Update on the treatment of Behçet's syndrome.关于白塞综合征治疗的最新进展。
Intern Emerg Med. 2019 Aug;14(5):661-675. doi: 10.1007/s11739-019-02035-1. Epub 2019 Jan 25.
2
Evidence for the use of intravenous immunoglobulins--a review of the literature.静脉注射免疫球蛋白的应用证据——文献综述。
Clin Rev Allergy Immunol. 2010 Apr;38(2-3):201-69. doi: 10.1007/s12016-009-8155-9.
3
Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.静脉注射免疫球蛋白在血管炎和结缔组织疾病中的治疗应用。
J Neurol. 2006 Sep;253 Suppl 5:V39-49. doi: 10.1007/s00415-006-5006-y.
4
[Use of i.v. immunoglobulins in neurology. Evidence-based consensus].[静脉注射免疫球蛋白在神经病学中的应用。循证共识]
Nervenarzt. 2004 Aug;75(8):801-15. doi: 10.1007/s00115-004-1733-4.
本文引用的文献
1
Modulation of mononuclear phagocyte function by intravenous gamma-globulin.静脉注射丙种球蛋白对单核吞噬细胞功能的调节
J Immunol. 1984 Feb;132(2):745-50.
2
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.大剂量静脉注射丙种球蛋白对针对凝血因子VIII（抗血友病因子）自身抗体的抗独特型抑制作用。
Lancet. 1984 Oct 6;2(8406):765-8. doi: 10.1016/s0140-6736(84)90701-3.
3
Transient neonatal Behcet's disease.短暂性新生儿贝赫切特病
Arch Dis Child. 1986 Aug;61(8):805-6. doi: 10.1136/adc.61.8.805.
4
Behçet's syndrome presenting as intracranial hypertension in a Caucasian.白塞病在一名高加索人中表现为颅内高压。
J R Soc Med. 1988 Aug;81(8):478-9. doi: 10.1177/014107688808100824.
5
Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.白塞病患者血小板前列环素敏感性降低。
Eur J Clin Invest. 1988 Aug;18(4):410-4. doi: 10.1111/j.1365-2362.1988.tb01032.x.
6
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.环孢素与秋水仙碱的双盲试验及环孢素治疗白塞病的长期开放性研究。
Lancet. 1989 May 20;1(8647):1093-6. doi: 10.1016/s0140-6736(89)92381-7.
Zotero 插件